Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment

Neuropharmacology

Volumn 76, Issue PART B, 2014, Pages 581-591

  Ashare, Rebecca L ^a   Falcone, Mary ^a   Lerman, Caryn ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Attention; Cognition; Nicotine; Smoking cessation; Withdrawal; Working memory

Indexed keywords

AMFEBUTAMONE; ATOMOXETINE; DONEPEZIL; GALANTAMINE; GUANFACINE; NICOTINE; RIVASTIGMINE; VARENICLINE;

ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ATTENTION DEFICIT DISORDER; ATTENTION DISTURBANCE; BEHAVIOR THERAPY; CLINICAL RESEARCH; COGNITION; COGNITIVE DEFECT; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DRUG THERAPY; GENETICS; HUMAN; MEMORY DISORDER; MENTAL DISEASE; NICOTINE REPLACEMENT THERAPY; NONHUMAN; PRIORITY JOURNAL; RESPONSE INHIBITION; REVIEW; RODENT; SCHIZOPHRENIA; SEX DIFFERENCE; SMOKING CESSATION; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME; WORKING MEMORY;

ATTENTION; COGNITION; NICOTINE; SMOKING CESSATION; WITHDRAWAL; WORKING MEMORY;

ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COGNITION DISORDERS; HUMANS; INHIBITION (PSYCHOLOGY); LEARNING DISORDERS; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER;

EID: 84887081090     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2013.04.034     Document Type: Review

References (222)

1. Y. Ago, K. Koda, K. Takuma, and T. Matsuda Pharmacological aspects of the acetylcholinesterase inhibitor galantamine J. Pharmacol. Sci. 116 2011 6 17
2. C.G. AhnAllen, P.G. Nestor, M.E. Shenton, R.W. McCarley, and M.A. Niznikiewicz Early nicotine withdrawal and transdermal nicotine effects on neurocognitive performance in schizophrenia Schizophr. Res. 100 2008 261 269 (Pubitemid 351324859)
3. C. Allison, and M. Shoaib Nicotine improves performance in an attentional set shifting task in rats Neuropharmacology 64 2013 314 320
4. J. Alvarez, and E. Emory Executive function and the frontal lobes: a meta-analytic review Neuropsychol. Rev. 16 2006 17 42 (Pubitemid 43954075)
5. J.T. Andreasen, G.M. Olsen, O. Wiborg, and J.P. Redrobe Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests J. Psychopharmacol. 23 2009 797 804
6. R.L. Ashare, and L.W. Hawk Jr. Effects of smoking abstinence on impulsive behavior among smokers high and low in ADHD-like symptoms Psychopharmacology (Berl) 219 2012 537 547
7. R.L. Ashare, and S.A. McKee Effects of varenicline and bupropion on cognitive processes among nicotine-deprived smokers Exp. Clin. Psychopharmacol. 20 2012 63 70
8. R.L. Ashare, R. Ray, C. Lerman, and A.A. Strasser Cognitive effects of the acetylcholinesterase inhibitor, donepezil, in healthy, non-treatment seeking smokers: a pilot feasibility study Drug Alcohol Depend. 126 2012 263 267
9. G. Atzori, C.A. Lemmonds, M.L. Kotler, M.J. Durcan, and J. Boyle Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal J. Clin. Psychopharmacol. 28 2008 667 674
10. A. Baddeley Working memory: looking back and looking forward Nat. Rev. Neurosci. 4 2003 829 839 (Pubitemid 37314405)
11. A. Baddeley Working Memory, Thought, and Action 2007 Oxford University Press
12. J.C. Ballard Assessing attention: comparison of response-inhibition and traditional continuous performance tests J. Clin. Exp. Neuropsychol. 23 2001 331 350 (Pubitemid 32579376)
13. A. Bancroft, and E.D. Levin Ventral hippocampal alpha4beta2 nicotinic receptors and chronic nicotine effects on memory Neuropharmacology 39 2000 2770 2778
14. R.S. Barr, M.A. Culhane, L.E. Jubelt, R.S. Mufti, M.A. Dyer, A.P. Weiss, T. Deckersbach, J.F. Kelly, O. Freudenreich, D.C. Goff, and A.E. Evins The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls Neuropsychopharmacology 33 2008 480 490
15. J.D. Beaver, C.J. Long, D.M. Cole, M.J. Durcan, L.C. Bannon, R.G. Mishra, and P.M. Matthews The effects of nicotine replacement on cognitive brain activity during smoking withdrawal studied with simultaneous fMRI/EEG Neuropsychopharmacology 36 2011 1792 1800
16. E.M. Bekker, K.B. Bocker, F. Van Hunsel, M.C. van den Berg, and J.L. Kenemans Acute effects of nicotine on attention and response inhibition Pharmacol. Biochem. Behav. 82 2005 539 548 (Pubitemid 41827597)
17. N.L. Benowitz, C.N. Lessov-Schlaggar, G.E. Swan, and P. Jacob 3rd Female sex and oral contraceptive use accelerate nicotine metabolism Clin. Pharmacol. Ther. 79 2006 480 488
18. J.H. Bettany, and E.D. Levin Ventral hippocampal alpha 7 nicotinic receptor blockade and chronic nicotine effects on memory performance in the radial-arm maze Pharmacol. Biochem. Behav. 70 2001 467 474 (Pubitemid 34131641)
19. J. Beuten, T.J. Payne, J.Z. Ma, and M.D. Li Significant association of catechol-O-methyltransferase (COMT) haplotypes with nicotine dependence in male and female smokers of two ethnic populations Neuropsychopharmacology 31 2006 675 684 (Pubitemid 43276983)
20. G. Biała, and M. Kruk Influence of bupropion and calcium channel antagonists on the nicotine-induced memory-related response of mice in the elevated plus maze Pharmacol. Rep. PR 61 2009 236
21. W.K. Bickel, R. Yi, R.D. Landes, P.F. Hill, and C. Baxter Remember the future: working memory training decreases delay discounting among stimulant addicts Biol. Psychiatry 69 2011 260 265
22. A. Biegon, S.W. Kim, J. Logan, J.M. Hooker, L. Muench, and J.S. Fowler Nicotine blocks brain estrogen synthase (aromatase): in vivo positron emission tomography studies in female baboons Biol. Psychiatry 67 2010 774 777
23. J. Birks Cholinesterase inhibitors for Alzheimer's disease Cochrane Database Syst. Rev. 2006 CD005593
24. A. Blondel, D.J. Sanger, and P.C. Moser Characterisation of the effects of nicotine in the five-choice serial reaction time task in rats: antagonist studies Psychopharmacology (Berl) 149 2000 293 305 (Pubitemid 30262344)
25. E. Bora, B.J. Harrison, M. Yucel, and C. Pantelis Cognitive impairment in euthymic major depressive disorder: a meta-analysis Psychol. Med. 2012 1 10
26. C.R. Breese, M.J. Marks, J. Logel, C.E. Adams, B. Sullivan, A.C. Collins, and S. Leonard Effect of smoking history on [3H]nicotine binding in human postmortem brain J. Pharmacol. Exp. Ther. 282 1997 7 13 (Pubitemid 27425521)
27. G.M. Bright Abuse of medications employed for the treatment of ADHD: results from a large-scale community survey Medscape J. Med. 10 2008 111
28. U. Broms, K. Silventoinen, P.A. Madden, A.C. Heath, and J. Kaprio Genetic architecture of smoking behavior: a study of Finnish adult twins Twin Res. Hum. Genet.: The Official Journal of the International Society for Twin Studies 9 2006 64 72 (Pubitemid 43384794)
29. R. Cabeza, Y.S. Mazuz, J. Stokes, J.E. Kragel, M.G. Woldorff, E. Ciaramelli, I.R. Olson, and M. Moscovitch Overlapping parietal activity in memory and perception: evidence for the attention to memory model J. Cogn. Neurosci. 23 2011 3209 3217
30. R. Cannady, R. Weir, B. Wee, E. Gotschlich, N. Kolia, E. Lau, J. Brotherton, and E.D. Levin Nicotinic antagonist effects in the mediodorsal thalamic nucleus: regional heterogeneity of nicotinic receptor involvement in cognitive function Biochem. Pharmacol. 78 2009 788 794
31. C.D. Chambers, H. Garavan, and M.A. Bellgrove Insights into the neural basis of response inhibition from cognitive and clinical neuroscience Neurosci. Biobehav. Rev. 33 2009 631 646
32. J. Chen, B.K. Lipska, N. Halim, Q.D. Ma, M. Matsumoto, S. Melhem, B.S. Kolachana, T.M. Hyde, M.M. Herman, J. Apud, M.F. Egan, J.E. Kleinman, and D.R. Weinberger Functional analysis of genetic variation in catechol-O- methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain Am. J. Hum. Genet. 75 2004 807 821 (Pubitemid 39390488)
33. L.Y. Chuah, and M.W. Chee Cholinergic augmentation modulates visual task performance in sleep-deprived young adults J. Neurosci. 28 2008 11369 11377
34. D.M. Cole, C.F. Beckmann, C.J. Long, P.M. Matthews, M.J. Durcan, and J.D. Beaver Nicotine replacement in abstinent smokers improves cognitive withdrawal symptoms with modulation of resting brain network dynamics Neuroimage 52 2010 590 599
35. S. Colilla, C. Lerman, P.G. Shields, C. Jepson, M. Rukstalis, J. Berlin, A. DeMichele, G. Bunin, B.L. Strom, and T.R. Rebbeck Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women Pharmacogenet. Genomics 15 2005 393 398 (Pubitemid 40835080)
36. P.J. Conn, and B.L. Roth Opportunities and challenges of psychiatric drug discovery: roles for scientists in academic, industry, and government settings Neuropsychopharmacology 33 2008 2048 2060 (Pubitemid 351992094)
37. C. Conners, and M. Staff Conners' Continuous Performance Test II: Computer Program for Windows Technical Guide and Software Manual 2000 Multi-Health Systems North Tonwanda, NY
38. B.A. Cornblatt, N.J. Risch, G. Faris, D. Friedman, and L. Erlenmeyer-Kimling The continuous performance test, identical pairs version (CPT-IP): I. new findings about sustained attention in normal families Psychiatry Res. 26 1988 223 238
39. K.P. Cosgrove, J. Batis, F. Bois, P.K. Maciejewski, I. Esterlis, T. Kloczynski, S. Stiklus, S. Krishnan-Sarin, S. O'Malley, E. Perry, G. Tamagnan, J.P. Seibyl, and J.K. Staley beta2-Nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking Arch. Gen. Psychiatry 66 2009 666 676
40. K.P. Cosgrove, I. Esterlis, S.A. McKee, F. Bois, J.P. Seibyl, C.M. Mazure, S. Krishnan-Sarin, J.K. Staley, M.R. Picciotto, and S.S. O'Malley Sex differences in availability of beta2*-nicotinic acetylcholine receptors in recently abstinent tobacco smokers Arch. Gen. Psychiatry 69 2012 418 427
41. J.T. Coull, C.D. Frith, R.S. Frackowiak, and P.M. Grasby A fronto-parietal network for rapid visual information processing: a PET study of sustained attention and working memory Neuropsychologia 34 1996 1085 1095 (Pubitemid 26345286)
42. L.S. Covey, J. Manubay, H. Jiang, M. Nortick, and D. Palumbo Smoking cessation and inattention or hyperactivity/impulsivity: a post hoc analysis Nicotine Tob. Res. 10 2008 1717 1725
43. M.A. Culhane, D.A. Schoenfeld, R.S. Barr, C. Cather, T. Deckersbach, O. Freudenreich, D.C. Goff, N.A. Rigotti, and A.E. Evins Predictors of early abstinence in smokers with schizophrenia J. Clin. Psychiatry 69 2008 1743 1750
44. V. David, M. Besson, J.P. Changeux, S. Granon, and P. Cazala Reinforcing effects of nicotine microinjections into the ventral tegmental area of mice: dependence on cholinergic nicotinic and dopaminergic D1 receptors Neuropharmacology 50 2006 1030 1040 (Pubitemid 44208837)
45. J.A. Davis, and T.J. Gould The effects of DHBE and MLA on nicotine-induced enhancement of contextual fear conditioning in C57BL/6 mice Psychopharmacology (Berl) 184 2006 345 352 (Pubitemid 43255851)
46. J.A. Davis, and T.J. Gould Atomoxetine reverses nicotine withdrawal-associated deficits in contextual fear conditioning Neuropsychopharmacology 2007
47. J.A. Davis, and T.J. Gould Associative learning, the hippocampus, and nicotine addiction Curr. Drug Abuse Rev. 1 2008 9 19
48. J.A. Davis, J.R. James, S.J. Siegel, and T.J. Gould Withdrawal from chronic nicotine administration impairs contextual fear conditioning in C57BL/6 mice J. Neurosci. 25 2005 8708 8713 (Pubitemid 41362049)
49. L. Dawkins, J.H. Powell, R. West, J. Powell, and A. Pickering A double-blind placebo-controlled experimental study of nicotine: II-Effects on response inhibition and executive functioning Psychopharmacology (Berl) 190 2007 457 467 (Pubitemid 46204463)
50. M. Day, J.B. Pan, M.J. Buckley, E. Cronin, P.R. Hollingsworth, W.D. Hirst, R. Navarra, J.P. Sullivan, M.W. Decker, and G.B. Fox Differential effects of ciproxifan and nicotine on impulsivity and attention measures in the 5-choice serial reaction time test Biochem. Pharmacol. 73 2007 1123 1134 (Pubitemid 46413175)
51. M. De Biasi, and J.A. Dani Reward, addiction, withdrawal to nicotine Annu. Rev. Neurosci. 34 2011 105 130
52. R. De la Garza 2nd, and J.H. Yoon Evaluation of the effects of rivastigmine on cigarette smoking by methamphetamine-dependent volunteers Prog. Neuropsychopharmacol. Bol. Psychiatry 35 2011 1827 1830
53. H. de Wit Impulsivity as a determinant and consequence of drug use: a review of underlying processes Addict. Biol. 14 2009 22 31
54. J. Delrieu, A. Piau, C. Caillaud, T. Voisin, and B. Vellas Managing cognitive dysfunction through the continuum of Alzheimer's disease: role of pharmacotherapy CNS Drugs 25 2011 213 226
55. A. Diehl, H. Nakovics, B. Croissant, M.N. Smolka, A. Batra, and K. Mann Galantamine reduces smoking in alcohol-dependent patients: a randomized, placebo-controlled trial Int. J. Clin. Pharmacol. Ther. 44 2006 614 622 (Pubitemid 44896139)
56. A. Diehl, H. Nakovics, J. Mutschler, D. Hermann, and F. Kiefer Rivastigmine reduces tobacco craving in alcohol-dependent smokers Pharmacopsychiatry 42 2009 89 94
57. D.E. Dluzen, and L.I. Anderson Estrogen differentially modulates nicotine-evoked dopamine release from the striatum of male and female rats Neurosci. Lett. 230 1997 140 142 (Pubitemid 27312403)
58. S.L. Dolan, K.A. Sacco, A. Termine, A.A. Seyal, M.M. Dudas, J.C. Vessicchio, B.E. Wexler, and T.P. George Neuropsychological deficits are associated with smoking cessation treatment failure in patients with schizophrenia Schizophr. Res. 70 2004 263 275 (Pubitemid 39141104)
59. D.E. Evans, and D.J. Drobes Nicotine self-medication of cognitive-attentional processing Addict. Biol. 14 2009 32 42
60. D.E. Evans, J.Y. Park, N. Maxfield, and D.J. Drobes Neurocognitive variation in smoking behavior and withdrawal: genetic and affective moderators Genes Brain Behav. 8 2009 86 96
61. A.E. Evins, T. Deckersbach, C. Cather, O. Freudenreich, M.A. Culhane, D.C. Henderson, M.F. Green, D.A. Schoenfeld, N.A. Rigotti, and D.C. Goff Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia J. Clin. Psychiatry 66 2005 1184 1190 (Pubitemid 41442287)
62. M. Falcone, E.P. Wileyto, K. Ruparel, R.T. Gerraty, L. LaPrate, J.A. Detre, R. Gur, J. Loughead, and C. Lerman Age-related differences in working memory deficits during nicotine withdrawal Addict. Biol. 2013 (E-pub March 19)
63. M. Farage, T. Osborn, and A. MacLean Cognitive, sensory, and emotional changes associated with the menstrual cycle: a review Arch. Gynecol. Obstet. 278 2008 299 307
64. S.B. Floresco, and J.D. Jentsch Pharmacological enhancement of memory and executive functioning in laboratory animals Neuropsychopharmacology 36 2011 227 250
65. N.S. Foldi, R.E.C. White, and L.A. Schaefer Detecting effects of donepezil on visual selective attention using signal detection parameters in Alzheimer's disease Int. J. Geriatr. Psychiatry 20 2005 485 488 (Pubitemid 40716343)
66. M.D. Fox, A.Z. Snyder, J.L. Vincent, M. Corbetta, D.C. Van Essen, and M.E. Raichle The human brain is intrinsically organized into dynamic, anticorrelated functional networks Proc. Natl. Acad. Sci. U. S. A. 102 2005 9673 9678 (Pubitemid 40981739)
67. B.F. Fuemmeler, S.H. Kollins, and F.J. McClernon Attention Deficit Hyperactivity Disorder Symptoms Predict Nicotine Dependence and Progression to Regular Smoking from Adolescence to Young Adulthood 2007 jsm051
68. A.J. Garvey, R.E. Bliss, J.L. Hitchcock, J.W. Heinold, and B. Rosner Predictors of smoking relapse among self-quitters: a report from the normative aging study Addict. Behav. 17 1992 367 377
69. T.P. George Neurobiological links between nicotine addiction and schizophrenia J. Dual Diagn. 3 2007 27 42 (Pubitemid 350171287)
70. T.P. George, J.C. Vessicchio, A. Termine, D.M. Sahady, C.A. Head, W.T. Pepper, T.R. Kosten, and B.E. Wexler Effects of smoking abstinence on visuospatial working memory function in schizophrenia Neuropsychopharmacology 26 2002 75 85 (Pubitemid 34075278)
71. D.G. Gilbert, A. Izetelny, R. Radtke, J. Hammersley, N.E. Rabinovich, T.R. Jameson, and J.I. Huggenvik Dopamine receptor (DRD2) genotype-dependent effects of nicotine on attention and distraction during rapid visual information processing Nicotine Tob. Res. 7 2005 361 379 (Pubitemid 41418709)
72. T.J. Gould, G.S. Portugal, J.M. André, M.P. Tadman, M.J. Marks, J.W. Kenney, E. Yildirim, and M. Adoff The duration of nicotine withdrawal-associated deficits in contextual fear conditioning parallels changes in hippocampal high affinity nicotinic acetylcholine receptor upregulation Neuropharmacology 62 2012 2118 2125
73. A. Green, K.A. Ellis, J. Ellis, C.F. Bartholomeusz, S. Ilic, R.J. Croft, K. Luan Phan, and P.J. Nathan Muscarinic and nicotinic receptor modulation of object and spatial n-back working memory in humans Pharmacol. Biochem. Behav. 81 2005 575 584 (Pubitemid 40966805)
74. J.E. Greenstein, and J.D. Kassel The effects of smoking and smoking abstinence on verbal and visuospatial working memory capacity Exp. Clin. Psychopharmacol. 17 2009 78 90
75. G. Gron, M. Kirstein, A. Thielscher, M.W. Riepe, and M. Spitzer Cholinergic enhancement of episodic memory in healthy young adults Psychopharmacology (Berl) 182 2005 170 179 (Pubitemid 41400874)
76. C.T. Gualtieri, and L.G. Johnson Bupropion normalizes cognitive performance in patients with depression MedGenMed: Medscape Gen. Med. 9 2007 22
77. B. Hahn, T.J. Ross, F.A. Wolkenberg, D.M. Shakleya, M.A. Huestis, and E.A. Stein Performance effects of nicotine during selective attention, divided attention, and simple stimulus detection: an fMRI study Cereb. Cortex 19 2009 1990 2000
78. B. Hahn, T.J. Ross, Y. Yang, I. Kim, M.A. Huestis, and E.A. Stein Nicotine enhances visuospatial attention by deactivating areas of the resting brain default network J. Neurosci. 27 2007 3477 3489 (Pubitemid 46515135)
79. B. Hahn, M. Shoaib, and I. Stolerman Selective nicotinic receptor antagonists: effects on attention and nicotine-induced attentional enhancement Psychopharmacology (Berl) 217 2011 75 82
80. T.A. Hare, C.F. Camerer, and A. Rangel Self-control in decision-making involves modulation of the vmPFC valuation system Science 324 2009 646 648
81. E.L. Harrison, S. Coppola, and S.A. McKee Nicotine deprivation and trait impulsivity affect smokers' performance on cognitive tasks of inhibition and attention Exp. Clin. Psychopharmacol. 17 2009 91 98
82. S.J. Heishman, B.A. Kleykamp, and E.G. Singleton Meta-analysis of the acute effects of nicotine and smoking on human performance Psychopharmacology (Berl) 210 2010 453 469
83. P. Hendricks, J. Ditre, D. Drobes, and T. Brandon The early time course of smoking withdrawal effects Psychopharmacology (Berl) 187 2006 385 396 (Pubitemid 44079930)
84. A. Herman, and M. Sofuoglu Cognitive effects of nicotine: genetic moderators Addict. Biol. 15 2010 250 265
85. M. Hirvonen, A. Laakso, K. Nagren, J.O. Rinne, T. Pohjalainen, and J. Hietala C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo Mol. Psychiatry 9 2004 1060 1061 (Pubitemid 40065447)
86. H. Hodges Maze procedures: the radial-arm and water maze compared Brain Res. Cogn. Brain Res. 3 1996 167 181 (Pubitemid 26198350)
87. W. Hofmann, B.J. Schmeichel, and A.D. Baddeley Executive functions and self-regulation Trends Cogn. Sci. 16 2012 174 180
88. L. Hong, G.K. Thaker, and R.P. McMahon Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder Arch. Gen. Psychiatry 68 2011 1195 1206
89. T.J. Hopkins, L.E. Rupprecht, M.R. Hayes, J.A. Blendy, and H.D. Schmidt Galantamine, an acetylcholinesterase inhibitor and positive allosteric modulator of nicotinic acetylcholine receptors, attenuates nicotine taking and seeking in rats Neuropsychopharmacology 37 2012 2310 2321
90. J.R. Hughes Tobacco withdrawal in self-quitters J. Consult. Clin. Psychol. 60 1992 689 697
91. J.R. Hughes Effects of abstinence from tobacco: valid symptoms and time course Nicotine Tob. Res. 9 2007 315 327 (Pubitemid 46404264)
92. G.L. Humfleet, J.J. Prochaska, M. Mengis, J. Cullen, R. Munoz, V. Reus, and S.M. Hall Preliminary evidence of the association between the history of childhood attention-deficit/hyperactivity disorder and smoking treatment failure Nicotine Tob. Res. 7 2005 453 460 (Pubitemid 41418718)
93. J.B. Hutchinson, M.R. Uncapher, and A.D. Wagner Posterior parietal cortex and episodic retrieval: convergent and divergent effects of attention and memory Learn. Mem. 16 2009 343 356
94. S. Ikemoto, M. Qin, and Z.H. Liu Primary reinforcing effects of nicotine are triggered from multiple regions both inside and outside the ventral tegmental area J. Neurosci. 26 2006 723 730 (Pubitemid 43237066)
95. L.K. Jacobsen, J.H. Krystal, W.E. Mencl, M. Westerveld, S.J. Frost, and K.R. Pugh Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers Biol. Psychiatry 57 2005 56 66 (Pubitemid 39647592)
96. L.K. Jacobsen, W.E. Mencl, R.T. Constable, M. Westerveld, and K.R. Pugh Impact of smoking abstinence on working memory neurocircuitry in adolescent daily tobacco smokers Psychopharmacology (Berl) 193 2007 557 566 (Pubitemid 47094373)
97. L.K. Jacobsen, K.R. Pugh, W.E. Mencl, and J. Gelernter C957T polymorphism of the dopamine D2 receptor gene modulates the effect of nicotine on working memory performance and cortical processing efficiency Psychopharmacology (Berl) 188 2006 530 540 (Pubitemid 46766441)
98. S.J. Japuntich, S.S. Smith, D.E. Jorenby, M.E. Piper, M.C. Fiore, and T.B. Baker Depression predicts smoking early but not late in a quit attempt Nicotine Tob. Res. 9 2007 677 686 (Pubitemid 46930318)
99. E.C. Johnstone, K.M. Elliot, S.P. David, M.F. Murphy, R.T. Walton, and M.R. Munafo Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial Cancer Epidemiol. Biomarkers Prev. 16 2007 1065 1069 (Pubitemid 46984939)
100. E.G. Jonsson, M.M. Nothen, F. Grunhage, L. Farde, Y. Nakashima, P. Propping, and G.C. Sedvall Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers Mol. Psychiatry 4 1999 290 296 (Pubitemid 29292183)
101. D.L. Kelly, R.P. McMahon, E. Weiner, D.L. Boggs, D. Dickinson, R.R. Conley, and R.W. Buchanan Lack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophrenia Schizophr. Res. 103 2008 161 168
102. K. Kendziorra, H. Wolf, P.M. Meyer, H. Barthel, S. Hesse, G.A. Becker, J. Luthardt, A. Schildan, M. Patt, D. Sorger, A. Seese, H.J. Gertz, and O. Sabri Decreased cerebral alpha4beta2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer's disease assessed with positron emission tomography Eur. J. Nucl. Med. Mol. Imaging 38 2011 515 525
103. J.W. Kenney, M.D. Adoff, D.S. Wilkinson, and T.J. Gould The effects of acute, chronic, and withdrawal from chronic nicotine on novel and spatial object recognition in male C57BL/6J mice Psychopharmacology (Berl) 217 2011 353 365
104. J.D. Killen, and S.P. Fortmann Craving is associated with smoking relapse: findings from three prospective studies Exp. Clin. Psychopharmacol. 5 1997 137 142 (Pubitemid 27239815)
105. J.S. Kim, and E.D. Levin Nicotinic, muscarinic and dopaminergic actions in the ventral hippocampus and the nucleus accumbens: effects on spatial working memory in rats Brain Res. 725 1996 231 240 (Pubitemid 27377785)
106. B.A. Kimmey, L.E. Rupprecht, M.R. Hayes, and H.D. Schmidt Donepezil, an acetylcholinesterase inhibitor, attenuates nicotine self-administration and reinstatement of nicotine seeking in rats Addict. Biol. 2012 (E-pub December 12)
107. A.P. Kirshenbaum, E.R. Jackson, S.J. Brown, J.R. Fuchs, B.C. Miltner, and A.H. Doughty Nicotine-induced impulsive action: sensitization and attenuation by mecamylamine Behav. Pharmacol. 22 2011 207 221
108. S. Kollins, J. English, M. Roley, B. O'Brien, J. Blair, S. Lane, and F.J. McClernon Effects of smoking abstinence on smoking-reinforced responding, withdrawal, and cognition in adults with and without attention deficit hyperactivity disorder Psychopharmacology (Berl) 2012 1 12
109. S.H. Kollins, F.J. McClernon, and J.N. Epstein Effects of smoking abstinence on reaction time variability in smokers with and without ADHD: an ex-Gaussian analysis Drug Alcohol Depend. 100 2009 169 172
110. S.H. Kollins, F.J. McClernon, and B.F. Fuemmeler Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults Arch. Gen. Psychiatry 62 2005 1142 1147 (Pubitemid 41396939)
111. K.Z. Kolokotroni, R.J. Rodgers, and A.A. Harrison Effects of chronic nicotine, nicotine withdrawal and subsequent nicotine challenges on behavioural inhibition in rats Psychopharmacology (Berl) 219 2012 453 468
112. J. Koontz, and A. Baskys Effects of galantamine on working memory and global functioning in patients with mild cognitive impairment: a double-blind placebo-controlled study Am. J. Alzheimer's Dis. Other Demen. 20 2005 295 302 (Pubitemid 41502371)
113. F. Kouneiher, S. Charron, and E. Koechlin Motivation and cognitive control in the human prefrontal cortex Nat. Neurosci. 12 2009 939 945
114. R.V. Kozink, S.H. Kollins, and F.J. McClernon Smoking withdrawal modulates right inferior frontal cortex but not presupplementary motor area activation during inhibitory control Neuropsychopharmacology 35 2010 2600 2606
115. R.V. Kozink, A.M. Lutz, J.E. Rose, B. Froeliger, and F.J. McClernon Smoking withdrawal shifts the spatiotemporal dynamics of neurocognition Addict. Biol. 15 2010 480 490
116. S. Krishnan-Sarin, B. Reynolds, A.M. Duhig, A. Smith, T. Liss, A. McFetridge, D.A. Cavallo, K.M. Carroll, and M.N. Potenza Behavioral impulsivity predicts treatment outcome in a smoking cessation program for adolescent smokers Drug Alcohol Depend. 88 2007 79 82 (Pubitemid 46400299)
117. M. Kruk-Słomka, B. Budzyńska, and G. Biała Involvement of cholinergic receptors in the different stages of memory measured in the modified elevated plus maze test in mice Pharmacol. Rep. PR 64 2012 1066
118. M. Kruk, K. Tendera, and G. Biala Memory-related effects of cholinergic receptor ligands in mice as measured by the elevated plus maze test Pharmacol. Rep. 63 2011 1372 1382
119. V. Kumari, and P. Postma Nicotine use in schizophrenia: the self medication hypotheses Neurosci. Biobehav. Rev. 29 2005 1021 1034 (Pubitemid 41097398)
120. A. Kuryatov, J. Onksen, and J. Lindstrom Roles of accessory subunits in α4β2* nicotinic receptors Mol. Pharmacol. 74 2008 132
121. H.M. Lachman, D.F. Papolos, T. Saito, Y.M. Yu, C.L. Szumlanski, and R.M. Weinshilboum Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders Pharmacogenetics 6 1996 243 250 (Pubitemid 26226317)
122. N.S. Lawrence, T.J. Ross, R. Hoffmann, H. Garavan, and E.A. Stein Multiple neuronal networks mediate sustained attention J. Cogn. Neurosci. 15 2003 1028 1038 (Pubitemid 37281766)
123. N.S. Lawrence, T.J. Ross, and E.A. Stein Cognitive mechanisms of nicotine on visual attention Neuron 36 2002 539 548 (Pubitemid 35284738)
124. C. Lerman, C. Jepson, E.P. Wileyto, L.H. Epstein, M. Rukstalis, F. Patterson, V. Kaufmann, S. Restine, L. Hawk, R. Niaura, and W. Berrettini Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials Neuropsychopharmacology 31 2006 231 242 (Pubitemid 43250960)
125. C. Lerman, M.G. LeSage, K.A. Perkins, S.S. O'Malley, S.J. Siegel, N.L. Benowitz, and W.A. Corrigall Translational research in medication development for nicotine dependence Nat. Rev. Drug Discov. 6 2007 746 762 (Pubitemid 47338182)
126. E.D. Levin, S.J. Briggs, N.C. Christopher, and J.T. Auman Working memory performance and cholinergic effects in the ventral tegmental area and substantia nigra Brain Res. 657 1994 165 170 (Pubitemid 24281261)
127. E.D. Levin, S.J. Briggs, N.C. Christopher, and J.E. Rose Chronic nicotinic stimulation and blockade effects on working memory Behav. Pharmacol. 4 1993 179 182 (Pubitemid 23105384)
128. E.D. Levin, C. Lee, J.E. Rose, A. Reyes, G. Ellison, M. Jarvik, and E. Gritz Chronic nicotine and withdrawal effects on radial-arm maze performance in rats Behav. Neural Biol. 53 1990 269 276 (Pubitemid 20249740)
129. E.D. Levin, F.J. McClernon, and A.H. Rezvani Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization Psychopharmacology (Berl) 184 2006 523 539 (Pubitemid 43255869)
130. E.D. Levin, and A.H. Rezvani Nicotinic treatment for cognitive dysfunction Curr. Drug Targets CNS Neurol. Disord. 1 2002 423 431
131. M.D. Lezak Neuropsychological Assessment 4e 2004 Oxford University Press USA
132. M.E. Liu, S.J. Tsai, S.Y. Jeang, S.L. Peng, S.L. Wu, M.C. Chen, Y.L. Tsai, and S.T. Yang Varenicline prevents affective and cognitive exacerbation during smoking abstinence in male patients with schizophrenia Psychiatry Res. 190 2011 79 84
133. P.D. Livingstone, J. Srinivasan, J.N.C. Kew, L.A. Dawson, C. Gotti, M. Moretti, M. Shoaib, and S. Wonnacott α7 and non-α7 nicotinic acetylcholine receptors modulate dopamine release in vitro and in vivo in the rat prefrontal cortex Eur. J. Neurosci. 29 2009 539 550
134. G.D. Logan On the ability to inhibit thought and action: a user's guide to the stop signal paradigm D.a.C.T.H. Dagenbach, Inhibitory Processes in Attention, Memory, and Language 1994 Academic Press San Diego 189 238
135. G.D. Logan, R.J. Schachar, and R. Tannock Impulsivity and inhibitory control Psychol. Sci. 8 1997 60 66
136. J. Loughead, R. Ray, E.P. Wileyto, K. Ruparel, P. Sanborn, S. Siegel, R.C. Gur, and C. Lerman Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers Biol. Psychiatry 67 2010 715 721
137. J. Loughead, E.P. Wileyto, J.N. Valdez, P. Sanborn, K. Tang, A.A. Strasser, K. Ruparel, R. Ray, R.C. Gur, and C. Lerman Effect of abstinence challenge on brain function and cognition in smokers differs by COMT genotype Mol. Psychiatry 14 2009 820 826
138. A. Markou, C. Chiamulera, M.A. Geyer, M. Tricklebank, and T. Steckler Removing obstacles in neuroscience drug discovery: the future path for animal models Neuropsychopharmacology 34 2009 74 89
139. F.J. McClernon, and S.H. Kollins ADHD and smoking: from genes to brain to behavior Ann. N. Y. Acad. Sci. 1141 2008 131 147
140. F.J. McClernon, S.H. Kollins, A.M. Lutz, D.P. Fitzgerald, D.W. Murray, C. Redman, and J.E. Rose Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder: results of a preliminary study Psychopharmacology (Berl) 197 2008 95 105
141. F.J. McClernon, E.E. Van Voorhees, J. English, M. Hallyburton, A. Holdaway, and S.H. Kollins Smoking withdrawal symptoms are more severe among smokers with ADHD and independent of ADHD symptom change: results from a 12-day contingency-managed abstinence trial Nicotine Tob. Res. 13 2011 784 792
142. A. Mendrek, J. Monterosso, S.L. Simon, M. Jarvik, A. Brody, R. Olmstead, C.P. Domier, M.S. Cohen, M. Ernst, and E.D. London Working memory in cigarette smokers: comparison to non-smokers and effects of abstinence Addict. Behav. 31 2006 833 844
143. V. Menon, and L.Q. Uddin Saliency, switching, attention and control: a network model of insula function Brain Struct. Funct. 214 2010 655 667
144. P.S. Merritt, A.R. Cobb, and G.I. Cook Sex differences in the cognitive effects of tobacco abstinence: a pilot study Exp. Clin. Psychopharmacol. 20 2012 258 263
145. E.M. Mitsis, K.P. Cosgrove, J.K. Staley, F. Bois, E.B. Frohlich, G.D. Tamagnan, K.M. Estok, J.P. Seibyl, and C.H. van Dyck Age-related decline in nicotinic receptor availability with [(123)I]5-IA-85380 SPECT Neurobiol. Aging 30 2009 1490 1497
146. T.G. Moss, K.A. Sacco, T.M. Allen, A.H. Weinberger, J.C. Vessicchio, and T.P. George Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia Drug Alcohol Depend. 104 2009 94 99
147. M.R. Munafo, E.C. Johnstone, B. Guo, M.F. Murphy, and P. Aveyard Association of COMT Val108/158Met genotype with smoking cessation Pharmacogenet. Genomics 18 2008 121 128
148. J.W. Murrough, B. Iacoviello, A. Neumeister, D.S. Charney, and D.V. Iosifescu Cognitive dysfunction in depression: neurocircuitry and new therapeutic strategies Neurobiol. Learn. Mem. 96 2011 553 563
149. C. Myers, R. Taylor, E. Moolchan, and S. Heishman Dose-related enhancement of mood and cognition in smokers administered nicotine nasal spray Neuropsychopharmacology 33 2008 588 598
150. P. Newhouse, K. Kellar, P. Aisen, H. White, K. Wesnes, E. Coderre, A. Pfaff, H. Wilkins, D. Howard, and E.D. Levin Nicotine treatment of mild cognitive impairment: a 6-month double-blind pilot clinical trial Neurology 78 2012 91 101
151. P.A. Newhouse, A.S. Potter, J.A. Dumas, and C.M. Thiel Functional brain
152. K.H. Nuechterlein, M.F. Green, R.S. Kern, L.E. Baade, D.M. Barch, J.D. Cohen, S. Essock, W.S. Fenton, F.J. Frese 3rd, J.M. Gold, T. Goldberg, R.K. Heaton, R.S. Keefe, H. Kraemer, R. Mesholam-Gately, L.J. Seidman, E. Stover, D.R. Weinberger, A.S. Young, S. Zalcman, and S.R. Marder The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity Am. J. Psychiatry 165 2008 203 213 (Pubitemid 351704520)
153. L.A. Ortega, B.A. Tracy, T.J. Gould, and V. Parikh Effects of chronic low- and high-dose nicotine on cognitive flexibility in C57BL/6J mice Behav. Brain Res. 238 2013 134 145
154. A.M. Owen, K.M. McMillan, A.R. Laird, and E. Bullmore N-back working memory paradigm: a meta-analysis of normative functional neuroimaging studies Hum. Brain Mapp. 25 2005 46 59 (Pubitemid 40656192)
155. A. Pandya, and J.L. Yakel Allosteric modulators of the [alpha] 4 [beta] 2 subtype of neuronal nicotinic acetylcholine receptors Biochem. Pharmacol. 82 2011 952 958
156. M. Paolini, and M. De Biasi Mechanistic insights into nicotine withdrawal Biochem. Pharmacol. 82 2011 996 1007
157. F. Patterson, C. Jepson, J. Loughead, K. Perkins, A. Strasser, S. Siegel, J. Frey, R. Gur, and C. Lerman Working memory deficits predict short-term smoking resumption following brief abstinence Drug Alcohol Depend. 106 2010 61 64
158. F. Patterson, C. Jepson, A.A. Strasser, J. Loughead, K.A. Perkins, R.C. Gur, J.M. Frey, S. Siegel, and C. Lerman Varenicline improves mood and cognition during smoking abstinence Biol. Psychiatry 65 2009 144 149
159. M.L. Pergadia, A.C. Heath, N.G. Martin, and P.A. Madden Genetic analyses of DSM-IV nicotine withdrawal in adult twins Psychol. Med. 36 2006 963 972 (Pubitemid 43827368)
160. K.A. Perkins, C. Lerman, C.A. Fonte, M. Mercincavage, M.L. Stitzer, K.N. Chengappa, and A. Jain Cross-validation of a new procedure for early screening of smoking cessation medications in humans Clin. Pharmacol. Ther. 88 2010 109 114
161. K.A. Perkins, C. Lerman, M. Stitzer, C.A. Fonte, J.L. Briski, J.A. Scott, and K.N. Chengappa Development of procedures for early screening of smoking cessation medications in humans Clin. Pharmacol. Ther. 84 2008 216 221
162. J.L. Perry, and M.E. Carroll The role of impulsive behavior in drug abuse Psychopharmacology (Berl) 200 2008 1 26
163. M.R. Picciotto, N.A. Addy, Y.S. Mineur, and D.H. Brunzell It is not "either/or": activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood Prog. Neurobiol. 84 2008 329 342
164. D.V. Poltavski, T.V. Petros, and J.E. Holm Lower but not higher doses of transdermal nicotine facilitate cognitive performance in smokers on gender non-preferred tasks Pharmacol. Biochem. Behav. 102 2012 423 433
165. C.S. Pomerleau, K.K. Downey, S.M. Snedecor, A.M. Mehringer, J.L. Marks, and O.F. Pomerleau Smoking patterns and abstinence effects in smokers with no ADHD, childhood ADHD, and adult ADHD symptomatology Addict. Behav. 28 2003 1149 1157 (Pubitemid 36808522)
166. R.B. Poorthuis, N.A. Goriounova, J.J. Couey, and H.D. Mansvelder Nicotinic actions on neuronal networks for cognition: general principles and long-term consequences Biochem. Pharmacol. 78 2009 668 676
167. G.S. Portugal, and T.J. Gould Bupropion dose-dependently reverses nicotine withdrawal deficits in contextual fear conditioning Pharmacol. Biochem. Behav. 88 2007 179 187 (Pubitemid 350116002)
168. G.S. Portugal, D.S. Wilkinson, J.W. Kenney, C. Sullivan, and T.J. Gould Strain-dependent effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning Behav. Genet. 42 2012 133 150
169. G.S. Portugal, D.S. Wilkinson, J.R. Turner, J.A. Blendy, and T.J. Gould Developmental effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning Neurobiol. Learn. Mem. 97 2012 482 494
170. A.S. Potter, and P.A. Newhouse Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder Pharmacol. Biochem. Behav. 88 2008 407 417 (Pubitemid 350266783)
171. J. Powell, L. Dawkins, R. West, and A. Pickering Relapse to smoking during unaided cessation: clinical, cognitive and motivational predictors Psychopharmacology (Berl) 212 2010 537 549
172. J.H. Powell, A.D. Pickering, L. Dawkins, R. West, and J.F. Powell Cognitive and psychological correlates of smoking abstinence, and predictors of successful cessation Addict. Behav. 29 2004 1407 1426 (Pubitemid 39165997)
173. R.L. Rabenstein, N.A. Addy, B.J. Caldarone, Y. Asaka, L.M. Gruenbaum, L.L. Peters, D.M. Gilligan, R.M. Fitzsimonds, and M.R. Picciotto Impaired synaptic plasticity and learning in mice lacking beta-adducin, an actin-regulating protein J. Neurosci. 25 2005 2138 2145 (Pubitemid 40289419)
174. M.E. Raichle, A.M. MacLeod, A.Z. Snyder, W.J. Powers, D.A. Gusnard, and G.L. Shulman A default mode of brain function Proc. Natl. Acad. Sci. U. S. A. 98 2001 676 682 (Pubitemid 32105102)
175. B.P. Ramos, and A.F. Arnsten Adrenergic pharmacology and cognition: focus on the prefrontal cortex Pharmacol. Ther. 113 2007 523 536 (Pubitemid 46365960)
176. R. Ray, M. Rukstalis, C. Jepson, A. Strasser, F. Patterson, K. Lynch, and C. Lerman Effects of atomoxetine on subjective and neurocognitive symptoms of nicotine abstinence J. Psychopharmacol. (Oxf) 23 2009 168
177. R. Ray, R.A. Schnoll, and C. Lerman Nicotine dependence: biology, behavior, and treatment Annu. Rev. Med. 60 2009 247 260
178. J.D. Raybuck, and T.J. Gould Nicotine withdrawal-induced deficits in trace fear conditioning in C57BL/6 mice - a role for high-affinity beta2 subunit-containing nicotinic acetylcholine receptors Eur. J. Neurosci. 29 2009 377 387
179. J.D. Raybuck, G.S. Portugal, C. Lerman, and T.J. Gould Varenicline ameliorates nicotine withdrawal-induced learning deficits in C57BL/6 mice Behav. Neurosci. 122 2008 1166
180. T.W. Robbins The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry Psychopharmacology (Berl) 163 2002 362 380
181. H. Rollema, M. Hajós, P.A. Seymour, R. Kozak, M.J. Majchrzak, V. Guanowsky, W.E. Horner, D.S. Chapin, W.E. Hoffmann, D.E. Johnson, S. McLean, J. Freeman, and K.E. Williams Preclinical pharmacology of the α4β2 nAChR partial agonist varenicline related to effects on reward, mood and cognition Biochem. Pharmacol. 78 2009 813 824
182. M. Rukstalis, C. Jepson, F. Patterson, and C. Lerman Increases in hyperactive-impulsive symptoms predict relapse among smokers in nicotine replacement therapy J. Subst. Abuse Treat. 28 2005 297 304 (Pubitemid 40733138)
183. C.R. Rush, S.T. Higgins, A.R. Vansickel, W.W. Stoops, J.A. Lile, and P.E. Glaser Methylphenidate increases cigarette smoking Psychopharmacology (Berl) 181 2005 781 789 (Pubitemid 41400764)
184. O. Sabri, K. Kendziorra, H. Wolf, H.J. Gertz, and P. Brust Acetylcholine receptors in dementia and mild cognitive impairment Eur. J. Nucl. Med. Mol. Imaging 35 Suppl. 1 2008 S30 S45
185. K.A. Sacco, A. Termine, A. Seyal, M.M. Dudas, J.C. Vessicchio, S. Krishnan-Sarin, P.I. Jatlow, B.E. Wexler, and T.P. George Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms Arch. Gen. Psychiatry 62 2005 649 659 (Pubitemid 40973440)
186. M. Sarter, B. Givens, and J.P. Bruno The cognitive neuroscience of sustained attention: where top-down meets bottom-up Brain Res. Rev. 35 2001 146 160 (Pubitemid 32411470)
187. M. Sarter, and G. Paolone Deficits in attentional control: cholinergic mechanisms and circuitry-based treatment approaches Behav. Neurosci. 125 2011 825 835
188. M. Sarter, V. Parikh, and W.M. Howe nAChR agonist-induced cognition enhancement: integration of cognitive and neuronal mechanisms Biochem. Pharmacol. 78 2009 658 667
189. S. Semenova, I.P. Stolerman, and A. Markou Chronic nicotine administration improves attention while nicotine withdrawal induces performance deficits in the 5-choice serial reaction time task in rats Pharmacol. Biochem. Behav. 87 2007 360 368 (Pubitemid 47101880)
190. M. Shoaib, and L. Bizarro Deficits in a sustained attention task following nicotine withdrawal in rats Psychopharmacology (Berl) 178 2005 211 222 (Pubitemid 40379216)
191. M. Sofuoglu Cognitive enhancement as a pharmacotherapy target for stimulant addiction Addiction 105 2010 38 48
192. M. Sofuoglu, and K.M. Carroll Effects of galantamine on cocaine use in chronic cocaine users Am. J. Addict. 20 2011 302 303
193. M. Sofuoglu, A.I. Herman, Y. Li, and A.J. Waters Galantamine attenuates some of the subjective effects of intravenous nicotine and improves performance on a Go No-Go task in abstinent cigarette smokers: a preliminary report Psychopharmacology (Berl) 2012 1 8
194. M. Sofuoglu, and M. Mooney Cholinergic functioning in stimulant addiction: implications for medications development CNS Drugs 23 2009 939 952
195. M. Sofuoglu, A.J. Waters, J. Poling, and K.M. Carroll Galantamine improves sustained attention in chronic cocaine users Exp. Clin. Psychopharmacol. 19 2011 11 19
196. S.C. Sonne, E.V. Nunes, H. Jiang, C. Tyson, J. Rotrosen, and M.S. Reid The relationship between depression and smoking cessation outcomes in treatment-seeking substance abusers Am. J. Addict. 19 2010 111 118
197. D. Sridharan, D.J. Levitin, and V. Menon A critical role for the right fronto-insular cortex in switching between central-executive and default-mode networks Proc. Natl. Acad. Sci. U. S. A. 105 2008 12569 12574
198. J.K. Staley, S. Krishnan-Sarin, K.P. Cosgrove, E. Krantzler, E. Frohlich, E. Perry, J.A. Dubin, K. Estok, E. Brenner, R.M. Baldwin, G.D. Tamagnan, J.P. Seibyl, P. Jatlow, M.R. Picciotto, E.D. London, S. O'Malley, and C.H. van Dyck Human tobacco smokers in early abstinence have higher levels of β2* nicotinic acetylcholine receptors than nonsmokers J. Neurosci. 26 2006 8707 8714 (Pubitemid 44319406)
199. J.A. Stapleton, G. Sutherland, C. O'Gara, L.I. Spirling, and D. Ball Association between DRD2/ANKK1 Taq1A genotypes, depression and smoking cessation with nicotine replacement therapy Pharmacogenet. Genomics 21 2011 447 453
200. C.S. Stevenson, S. Whitmont, L. Bornholt, D. Livesey, and R.J. Stevenson A cognitive remediation programme for adults with attention deficit hyperactivity disorder Aust. N. Z. J. Psychiatry 36 2002 610 616 (Pubitemid 35174399)
201. A.A. Strasser, V. Kaufmann, C. Jepson, K.A. Perkins, W.B. Pickworth, E.P. Wileyto, M. Rukstalis, J. Audrain-McGovern, and C. Lerman Effects of different nicotine replacement therapies on postcessation psychological responses Addict. Behav. 30 2005 9 17 (Pubitemid 39550435)
202. L.H. Sweet, R.C. Mulligan, C.E. Finnerty, B.A. Jerskey, S.P. David, R.A. Cohen, and R.S. Niaura Effects of nicotine withdrawal on verbal working memory and associated brain response Psychiatry Res. 183 2010 69 74
203. D. Swick, V. Ashley, and U. Turken Are the neural correlates of stopping and not going identical? Quantitative meta-analysis of two response inhibition tasks Neuroimage 56 2011 1655 1665
204. V. Teneggi, S.T. Tiffany, L. Squassante, S. Milleri, L. Ziviani, and A. Bye Effect of sustained-release (SR) bupropion on craving and withdrawal in smokers deprived of cigarettes for 72 h Psychopharmacology (Berl) 183 2005 1 12 (Pubitemid 41484177)
205. A.V. Terry, and J.J. Buccafusco The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development J. Pharmacol. Exp. Ther. 306 2003 821
206. M. Trimmel, and S. Wittberger Effects of transdermally administered nicotine on aspects of attention, task load, and mood in women and men Pharmacol. Biochem. Behav. 78 2004 639 645 (Pubitemid 38901031)
207. L.M. Tuesta, C.D. Fowler, and P.J. Kenny Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior Biochem. Pharmacol. 82 2011 984 995
208. J.R. Turner, L.M. Castellano, and J.A. Blendy Parallel anxiolytic-like effects and upregulation of neuronal nicotinic acetylcholine receptors following chronic nicotine and varenicline Nicotine Tob. Res. 13 2011 41 46
209. A.R. Vansickel, W.W. Stoops, P.E. Glaser, M.M. Poole, and C.R. Rush Methylphenidate increases cigarette smoking in participants with ADHD Psychopharmacology (Berl) 218 2011 381 390
210. A.R. Vansickel, W.W. Stoops, P.E. Glaser, and C.R. Rush A pharmacological analysis of stimulant-induced increases in smoking Psychopharmacology (Berl) 2007
211. A.H. Weinberger, C.E. Pilver, R.A. Desai, C.M. Mazure, and S.A. McKee The relationship of major depressive disorder and gender to changes in smoking for current and former smokers: longitudinal evaluation in the US population Addiction 107 2012 1847 1856
212. A.H. Weinberger, C.E. Pilver, R.A. Desai, C.M. Mazure, and S.A. McKee The relationship of dysthymia, minor depression, and gender to changes in smoking for current and former smokers: longitudinal evaluation in the U.S. population Drug Alcohol Depend. 127 2013 170 176
213. K. Wild, D. Howieson, F. Webbe, A. Seelye, and J. Kaye Status of computerized cognitive testing in aging: a systematic review Alzheimer's Dement.: the journal of the Alzheimer's Association 4 2008 428 437
214. T.E. Wilens, M. Vitulano, H. Upadhyaya, J. Adamson, R. Sawtelle, L. Utzinger, and J. Biederman Cigarette smoking associated with attention deficit hyperactivity disorder J. Pediatrics 153 2008 414 419
215. D. Wilkinson, J. Turner, J. Blendy, and T. Gould Genetic background influences the effects of withdrawal from chronic nicotine on learning and high-affinity nicotinic acetylcholine receptor binding in the dorsal and ventral hippocampus Psychopharmacology (Berl) 2012 1 8
216. D.S. Wilkinson, and T.J. Gould The effects of galantamine on nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6 mice Behav. Brain Res. 223 2011 53 57
217. S. Wonnacott Presynaptic nicotinic ACh receptors Trends Neurosci. 20 1997 92 98 (Pubitemid 27050704)
218. J.A. Wouda, D. Riga, W. De Vries, M. Stegeman, Y. van Mourik, D. Schetters, A.N.M. Schoffelmeer, T. Pattij, and T.J. De Vries Varenicline attenuates cue-induced relapse to alcohol, but not nicotine seeking, while reducing inhibitory response control Psychopharmacology (Berl) 2011 1 11
219. T. Wykes, V. Huddy, C. Cellard, S.R. McGurk, and P. Czobor A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes Am. J. Psychiatry 168 2011 472 485
220. H. Xian, J.F. Scherrer, P.A. Madden, M.J. Lyons, M. Tsuang, W.R. True, and S.A. Eisen The heritability of failed smoking cessation and nicotine withdrawal in twins who smoked and attempted to quit Nicotine Tob. Res. 5 2003 245 254 (Pubitemid 36547008)
221. J. Xu, A. Mendrek, M.S. Cohen, J. Monterosso, P. Rodriguez, S.L. Simon, A. Brody, M. Jarvik, C.P. Domier, R. Olmstead, M. Ernst, and E.D. London Brain activity in cigarette smokers performing a working memory task: effect of smoking abstinence Biol. Psychiatry 58 2005 143 150 (Pubitemid 41008131)
222. J. Xu, A. Mendrek, M.S. Cohen, J. Monterosso, S. Simon, A.L. Brody, M. Jarvik, P. Rodriguez, M. Ernst, and E.D. London Effects of acute smoking on brain activity vary with abstinence in smokers performing the N-Back task: a preliminary study Psychiatry Res. 148 2006 103 109 (Pubitemid 44781180)